Marijuana Exposure in Kids Rose after Recreational Use Legalized in Colorado

EMBARGOED FOR RELEASE: 11A.M. (ET), MONDAY, JULY 25, 2016

Media Advisory: To contact corresponding study author George Sam Wang, M.D., call Mark Couch at 303-724-5377  or email mark.couch@ucdenver.edu.

Video and Audio Content: The JAMA Report video and audio will be available under embargo at 2 p.m. ET on Thursday at this link and include broadcast-quality downloadable video and audio files, B-roll, scripts and other images. Please email JAMAReport@synapticdigital.com with any questions.

To place an electronic embedded link to this study in your story Links will be live at the embargo time: http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2016.0971

 

JAMA Pediatrics

The legalization of recreational marijuana in Colorado was associated with both increased hospital visits and cases at a regional poison center because of unintentional exposure to the drug by children, suggesting effective preventive measures are needed as more states consider legalizing the drug, according to an article published online by JAMA Pediatrics.

More than half of U.S. states allowed medical marijuana and four states allowed recreational marijuana use as of 2015. Colorado is one of those states, having allowed medical marijuana in 2000 and recreational marijuana becoming available for purchase in 2014.

George Sam Wang, M.D., of the University of Colorado Anschutz Medical Campus, Aurora, and coauthors examined the effect of the legalization of recreational marijuana on unintentional pediatric exposures.

The authors evaluated data on hospital admissions at a tertiary children’s hospital and cases at a regional poison center (RPC) between 2009 and 2015. Study participants included children younger than 10 years who were evaluated at the hospital’s emergency department, urgent care centers or an inpatient unit and RPC cases for marijuana exposure.

The authors identified 81 children – 62 included in the analysis – evaluated at the hospital and 163 marijuana exposure calls to a Colorado RPC. The median age of children who visited the hospital was 2.4 years and 2 years for children in RPC cases.

The authors report these findings:

  • The average rate of marijuana-related visits to the children’s hospital increased from 1.2 per 100,000 population two years prior to legalization to 2.3 per 100,000 population two years after legalization.
  • Annual RPC pediatric marijuana cases increased more than 5-fold from nine in 2009 to 47 in 2015.
  • Colorado saw an average 34 percent increase in RPC cases per year compared with a 19 percent increase in the rest of the United States.
  • Sources of marijuana were a parent, grandparent, neighbor, friend, babysitter or other family member.
  • Most pediatric marijuana exposures involved infused edible products; many exposures happened because marijuana products weren’t in child-resistant containers, there was poor child supervision or product storage issues.
  • The median length of hospital stay for marijuana-exposed children was 11 hours.
  • Clinical effects of marijuana exposure included drowsiness/lethargy, ataxia/dizziness, agitation, vomiting, tachycardia, dystonia/muscle rigidity, respiratory depression, bradycardia/hypotension and seizures.

Limitations of the study include that the results may not be generalizable to other states and that the electronic medical records and RPC data may have had missing information.

“Identifying successful preventive strategies requires further investigation. As more states pass laws legalizing recreational marijuana, legislators and health care professionals will need to consider strategies to decrease its effect on the pediatrics population,” the authors conclude.

(JAMA Pediatr. Published online July 25, 2016. doi:10.1001/jamapediatrics.2016.0971. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor’s Note: The study includes conflict of interest disclosures. Please see article for additional information, including other authors, author contributions and affiliations, etc.

 

#  #  #

 

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.